• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Alkermes plc (ALKS)

    -NasdaqGS
    72.25 Up 0.06(0.08%) Jan 30, 4:00PM EST
    |After Hours : 72.25 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:72.19
    Open:71.88
    Bid:62.30 x 100
    Ask:N/A
    1y Target Est:64.36
    Beta:1.83
    Next Earnings Date:N/A
    Day's Range:71.48 - 73.69
    52wk Range:38.49 - 73.69
    Volume:1,238,982
    Avg Vol (3m):1,048,360
    Market Cap:10.57B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 0.08%10.57B
    ABTDown 1.10%67.40B
    LLYDown 0.15%77.01B
    GSKDown 2.57%105.78B

    Key Statistics

    Forward P/E (1 yr):289.00
    P/S (ttm):18.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.27
    Quarterly EPS Est (Dec-14) :0.03
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):40.51

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback